Topics

Nobody should go through the horror of experiencing a second #heartattack, but even after a year, risk remains. We want to help patients navigate this distressing and life-changing experience by creating a more seamless pathway to help overcome treatment

14:00 EST 10 Nov 2019 | AztraZeneca

Nobody should go through the horror of experiencing a second , but even after a year, risk remains. We want to help patients navigate this distressing and life-changing experience by creating a more seamless pathway to help overcome treatment barriers.

Original Article: Nobody should go through the horror of experiencing a second #heartattack, but even after a year, risk remains. We want to help patients navigate this distressing and life-changing experience by creating a more seamless pathway to help overcome treatment

NEXT ARTICLE

More From BioPortfolio on "Nobody should go through the horror of experiencing a second #heartattack, but even after a year, risk remains. We want to help patients navigate this distressing and life-changing experience by creating a more seamless pathway to help overcome treatment "

Quick Search